These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 25533683

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics.
    Devetzis V, Daryadel A, Roumeliotis S, Theodoridis M, Wagner CA, Hettwer S, Huynh-Do U, Ploumis P, Arampatzis S.
    PLoS One; 2015; 10(12):e0143524. PubMed ID: 26630274
    [Abstract] [Full Text] [Related]

  • 24. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ.
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
    Moriya T, Tanaka S, Sone H, Ishibashi S, Matsunaga S, Ohashi Y, Akanuma Y, Haneda M, Katayama S.
    J Diabetes Complications; 2017 Feb; 31(2):473-478. PubMed ID: 27396240
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy.
    Furuichi K, Shimizu M, Yuzawa Y, Hara A, Toyama T, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ubara Y, Hohino J, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Kohagura K, Ogawa D, Mise K, Shibagaki Y, Makino H, Matsuo S, Wada T, Research Group of Diabetic Nephropathy, Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development.
    Clin Exp Nephrol; 2018 Jun; 22(3):570-582. PubMed ID: 29080120
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The association of hematuria on kidney clinicopathologic features and renal outcome in patients with diabetic nephropathy: a biopsy-based study.
    Wu Y, Zhang J, Wang Y, Wang T, Han Q, Guo R, Zhang R, Ren H, Zhu Y, Xu H, Li L, Tong N, Liu F.
    J Endocrinol Invest; 2020 Sep; 43(9):1213-1220. PubMed ID: 32147762
    [Abstract] [Full Text] [Related]

  • 32. Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
    Fufaa GD, Weil EJ, Lemley KV, Knowler WC, Brosius FC, Yee B, Mauer M, Nelson RG.
    Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):254-61. PubMed ID: 26792530
    [Abstract] [Full Text] [Related]

  • 33. Plasma D-dimer levels are associated with disease progression in diabetic nephropathy: a two-center cohort study.
    Yu Y, Zhu C, Lin Y, Qian Q, Shen X, Zou W, Wang M, Gong J, Chen M, Liu L, Yu R, Shen Q, Shao L, Zhu B.
    Ren Fail; 2023 Feb 05; 45(2):2285868. PubMed ID: 38013428
    [Abstract] [Full Text] [Related]

  • 34. Nephrotic range proteinuria as a strong risk factor for rapid renal function decline during pre-dialysis phase in type 2 diabetic patients with severely impaired renal function.
    Kitai Y, Doi Y, Osaki K, Sugioka S, Koshikawa M, Sugawara A.
    Clin Exp Nephrol; 2015 Dec 05; 19(6):1037-43. PubMed ID: 25680889
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.
    Panduru NM, Saraheimo M, Forsblom C, Thorn LM, Gordin D, Wadén J, Tolonen N, Bierhaus A, Humpert PM, Groop PH, FinnDiane Study Group.
    Diabetes Care; 2015 May 05; 38(5):883-90. PubMed ID: 25720601
    [Abstract] [Full Text] [Related]

  • 37. Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy.
    Pistrosch F, Passauer J, Herbrig K, Schwanebeck U, Gross P, Bornstein SR.
    Horm Metab Res; 2012 Nov 05; 44(12):914-8. PubMed ID: 22723267
    [Abstract] [Full Text] [Related]

  • 38. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
    Lee CH, Hui EY, Woo YC, Yeung CY, Chow WS, Yuen MM, Fong CH, Xu A, Lam KS.
    J Clin Endocrinol Metab; 2015 Apr 05; 100(4):1368-75. PubMed ID: 25625802
    [Abstract] [Full Text] [Related]

  • 39. Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients.
    Nielsen SE, Reinhard H, Zdunek D, Hess G, Gutiérrez OM, Wolf M, Parving HH, Jacobsen PK, Rossing P.
    Diabetes Res Clin Pract; 2012 Jul 05; 97(1):71-6. PubMed ID: 22402306
    [Abstract] [Full Text] [Related]

  • 40. Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression.
    Zhang J, Xiao X, Wu Y, Yang J, Zou Y, Zhao Y, Yang Q, Liu F.
    Nutrients; 2022 Sep 02; 14(17):. PubMed ID: 36079889
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.